Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;182(5):1093-1103.
doi: 10.1002/ajmg.a.61530. Epub 2020 Mar 7.

Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature

Affiliations

Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature

Jad M El Abiad et al. Am J Med Genet A. 2020 May.

Abstract

Ollier disease (OD) and Maffucci syndrome (MS) are characterized by multiple enchondromas. Patients with MS also have benign vascular overgrowths that become malignant in 8.5% of cases. OD is characterized by multiple enchondromas, typically unilateral in distribution with a predilection for the appendicular skeleton. MS is characterized by multiple enchondromas bilaterally distributed in most of the cases. Both disorders feature multiple swellings on the extremity, deformity around the joints, limitations in joint mobility, scoliosis, bone shortening, leg-length discrepancy, gait disturbances, pain, loss of function, and pathological fractures. About 50% of patients with OD or MS develop a malignancy, such as chondrosarcoma, glioma, and ovarian juvenile granulosa cell tumor. To better understand the natural history of OD and MS, we reviewed 287 papers describing patients with OD and MS. We also created a survey that was distributed directly to 162 patients through Facebook. Here, we compare the review of the cases described in the literature to the survey's responses. The review of the literature showed that: the patients with OD are diagnosed at a younger age; the prevalence of chondrosarcomas among patients with OD or MS was ~30%; in four patients, vascular anomalies were identified in internal organs only; and, the prevalence of cancer among patients with OD or MS was ~50%. With these data, health care providers will better understand the natural history, severity, and prognosis of these diseases and the prevalence of malignancies in these patients. Here, we recommend new guidelines for the care of patients with OD and MS.

Keywords: Maffucci syndrome; Ollier disease; enchondroma; malignancy; natural history; vascular anomaly.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

References

    1. Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F, … Hogendoom PC (2011). IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. The Journal of Pathology, 224, 334–343. 10.1002/path.2913 - DOI - PubMed
    1. Beltrami G, Ristori G, Scoccianti G, Tamburini A, & Capanna R. (2016). Hereditary multiple exostoses: A review of clinical appearance and metabolic pattern. Clinical Cases in Mineral and Bone Metabolism, 13, 110–118. 10.11138/ccmbm/2016.13.2.110 - DOI - PMC - PubMed
    1. Burgetova A, Matejovsky Z, Zikan M, Slama J, Dundr P, Skapa P, … Fischerova D. (2017). The association of enchondromatosis with malignant transformed chondrosarcoma and ovarian juvenile granulosa cell tumor (Ollier disease). Taiwanese Journal of Obstetrics & Gynecology, 56, 253–257. 10.1016/j.tjog.2017.02.00 - DOI - PubMed
    1. Couvineau A, Wouters V, Bertrand G, Rouyer C, Gérard B, Boon LM, … Silve C. (2008). PTHR1 mutations associated with Ollier disease result in receptor loss of function. Human Molecular Genetics, 17, 2766–2775. 10.1093/hmg/ddn176 - DOI - PMC - PubMed
    1. Fletcher DM, Unni KK, & Mertens F. (2002). WHO Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics of Tumours of Soft Tissue and Bone (pp. 234–257). Lyon, France: IARC Press.

MeSH terms

Supplementary concepts